
ãæ¿åºãã¯ã¯ãã³ã®å¯äœçšãžã®å¯Ÿå¿ãæãããšã¯ãã¯ã¯ãã³æ¯æã§ã¯ãªãåç§åŠã§ããã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ã¢ã³ãœããŒã»ããªã³ãã¯ããžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ã®COVID-19ã¯ã¯ãã³ãæ¥çš®åŸã衰匱æ§ã®ã®ã©ã³ã»ãã¬ãŒçå矀ãçºçããããããã3幎åãçµéããããæ¿åºãšå ¬è¡è¡çåœå±ã¯COVID-19ã¯ã¯ãã³ã«é¢é£ããå¯äœçšã®çå®ãçŽèŠããããšããªããšåœŒã¯èšãã
3幎ååãç§ã¯ã€ã³ã»ã³-ãžã§ã³ãœã³ïŒãžã§ã³ãœã³ïŒJïŒJïŒç€Ÿã®COVID-19ãŠã€ã«ã¹ãã¯ã¿ãŒã¯ã¯ãã³ãæ¥çš®ããåŸãã®ã©ã³ã»ãã¬ãŒçå矀ïŒGBSïŒãçºçããŸããã
ãã®ç¥çµçŸæ£ã«ãããæè¶³ã®ãã³ããç¶ãããµãã€ããŠæ©ãããšãé£ããã衰匱ãããããªç²åŽãšæŠã£ãŠããŸãããŸãããã®çç¶ã¯ç§ã ãã§ãªããä»ã®äœå人ãã®äººã ãæ¿åºãå ¬è¡è¡çæ©é¢ããç¡èŠããã声ãèããŠããããªãç¶æ ã«è¿œããã£ãŠããŸãã
2021幎ã«ç§ã¯ãã®çµéšãããã¹ãã³ã»ã°ããŒããã«å¯çš¿ããŸãããåœæãç±³é£åå»è¬åå±ïŒFDAïŒã¯JïŒJã®ã¯ã¯ãã³ã«èŠåã远å ãããã®å¯äœçšã®çºçã容èªã§ããªããã®ã§ãããšæèšããŸããã
ãã®éãç§ã¯ã¯ã¯ãã³ã®å¯äœçšã«ã€ããŠè©±ãããšãããã«å°é£ã§ããããåããå ¬è¡è¡çåœå±ãæ¿åºããã®äºå®ã«æ£çŽã«åãåãã¹ãã ãšäž»åŒµããŸããã
ç§ã¯ãã人ã ã¯çå®ãåãæ¢ããããšãã§ããããšè¿°ã¹ãåé¡ãçºçããçšãªã±ãŒã¹ãèªããããšã§ãã¯ã¯ãã³ã¡ãŒã«ãŒãããè¯ã補åãèšèšã§ãããšåŒ·èª¿ããŸããã
ããã3幎ãçµéããä»ããããã¯å®çŸããŠããŸãããå ¬è¡è¡çåœå±ã¯ãåã¯ã¯ãã³æŽŸãžã®æãããããCOVID-19ã¯ã¯ãã³ã¯å®å šã§å¹æçã§ããããšããç«å Žãå æããŠããŸãããããŠãããã«ãã»ã¬ãŒã¬ã³å€§çµ±é ã®äžã§èšç«ãããã¯ã¯ãã³ã«ãã被害è ãææžããæ¢åã®å¶åºŠã¯ãã»ãŒæŸæ£ãããç¶æ ã§ãã
ãã¡ãããã¯ã¯ãã³ã¯åœãæããŸããããããæ£åœãªã¯ã¯ãã³å¯äœçšã«å¯ŸããŠãåé¡ã¯äœããªãããšããå§¿å¢ãåãç¶ããããšã¯ãæ¿åºãç§ãã¡ãæ¯ãã圹å²ãæããããšãã補åã®æ¬ é¥ã远åããããšã劚ããŠããŸããããã¯ããã¡ã€ã³ã¬ã¿ã¹ãã©ã³ãããŒããæ±æãããå Žåãããšã¢ããã°ãæ£åžžã«æ©èœããªãå Žåãšåãããã«è¡ãããã¹ãããšã§ãã
ãããŠå»çæ¥çã§ã¯ããç¥ãããŠããããšã§ãããå®éã«æ¬ é¥ããããŸããããã€ãã®ã¯ã¯ãã³ã¯GBSã«é¢é£ããåé¡ãæ±ããŠããŸãã1976幎ã«ã¯ãè±ã€ã³ãã«ãšã³ã¶ã®ã¯ã¯ãã³ãå€ãã®GBSçäŸãåŒãèµ·ãããããã䜿çšäžæ¢ã«è¿œã蟌ãŸããŸãããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãããããã«ãªã¹ã¯ãäžæããããšãããŠããŸãã
æè¿ã§ã¯ã垯ç¶ç±ç¹ã¯ã¯ãã³ãRSVïŒåŒåžåšåèäœãŠã€ã«ã¹ïŒã¯ã¯ãã³ã®ã¡ãŒã«ãŒããã®ã©ã³ã»ãã¬ãŒçå矀ïŒGBSïŒã«é¢ããèŠåãåºããããåŸãªããªã£ãŠããŸãã
çŽæçã«èããŠãçŽåŸã§ããŸããGBSã¯æ¬è³ªçã«èªå·±å ç«åå¿ã§ããã¯ã¯ãã³ã¯ãå ç«ç³»ããã ãŸããããšã§æšçïŒããšãã°ãã³ãããŠã€ã«ã¹ã®æ§é ãæš¡å£ãããã®ïŒãæ»æãããä»çµã¿ã§ãããäžéšã®äººã ã§ã¯ç°åžžæäœãæŽèµ°ããæ«æ¢¢ç¥çµç³»ãæ»æãããšããæ²æšã§æ·±å»ãªã誀å°ããèµ·ããã®ã§ãã
æ®éã§ããã°ãå ¬è¡è¡çåœå±ã¯ãã®åé¡ãé ãããšã§ãããã£ãŠã¯ã¯ãã³ãžã®ç念ãå©é·ãããããªäºæ ãé¿ããããšèããã¯ãã§ãã
ããããä»ã®åœïŒã«ãããªã©ïŒããã®åé¡ã«å¯ŸããŠççŽãã€å·éã«å¯Ÿå¿ããŠããã®ãšã¯å¯Ÿç §çã«ãã¢ã¡ãªã«ã§ã¯é©åãªç®¡çããªãããŠãããããã®çµæãCOVID-19ã¯ã¯ãã³ãæ¥çš®ãã2å3000äžäººã®ãã¡ãã»ãã®ããããšã¯ããäœå人ãã®äººã ãèŠããã§ããŸãã
ãã®ç¶æ³ã¯æ¬æ¥é¿ããããã¯ãã§ããåé¡ã«å¯ŸåŠããããã®å¶åºŠã¯æ¢ã«ååšããŠããŸãããã¯ã¯ãã³éçºãä¿é²ããããã«è£œè¬äŒç€Ÿã蚎èšããå 責ããåŸã1986幎ã«å¶å®ããããå°å ã¯ã¯ãã³è¢«å®³è£åæ³ãïŒChildhood Vaccine Injury ActïŒã¯ããåœå®¶ã¯ã¯ãã³è¢«å®³è£åããã°ã©ã ïŒVICPïŒããèšç«ããŸããã
ãã®ããã°ã©ã ã§ã¯ãã¯ã¯ãã³ã«ãã被害ãåãã人ããã®çµéšãå ¬åŒã«èšé²ããè£åãåããããšãã§ããŸããè£åã¯ã¯ã¯ãã³ã«èª²ãããããããªèª²çšã§è³ãããŠããã察象ã¯ã¯ãã³ã«ã¯ç Žå·é¢šã麻ç¹ã颚ç¹ãããªãªãBåèçãã€ã³ãã«ãšã³ã¶ãªã©ãå«ãŸããŠããŸããè«æ±ã¯ç±³åœé£éŠè«æ±è£å€æã®ç¹å¥å€äºã«ãã£ãŠå¯©çãããŸãã
ãããã9/11ã®ããæ»æåŸã«æ¥ããããã§äœãããã察ç被害è£åããã°ã©ã ãïŒCountermeasures Injury Compensation Program, CICPïŒã«ãã£ãŠããã®åççãªå¶åºŠã¯äºå®äžåã£ãŠä»£ããããŸããã
å ¬è¡è¡çç·æ¥äºæ ã®éã«ãããšãã°éå£å€©ç¶çã¯ã¯ãã³æ¥çš®ã«ããå¯äœçšãçºçããå ŽåãCICPã§ã¯æäœéã®è£åãšããŠã倱ãããè³éãå»çè²»ã®è«æ±ãå¯èœã§ãã
ããããCOVID-19ãã³ãããã¯ãšãããã€ãŠãªãå ¬è¡è¡çç·æ¥äºæ ã®äžã§ããã®å¶åºŠããã®åœ¹å²ãæãããŠããªãããšãæããã«ãªããŸãããå€ãã®è«æ±ãäžæ¹çã«åŽäžãããæè¿ã®å€§èŠæš¡ãªè£åãé€ãã°ããããŸã§ã®è£åã¯ãã£ã15ä»¶ãç·é¡6äžãã«æªæºã§ããã®äžã«GBSã«å¯Ÿããè£åã¯äžä»¶ããããŸããã
COVID-19ã¯ã¯ãã³ãããã广çã«æ©èœããŠããVICPã®å¯Ÿè±¡ã«ããã°ããã®ã§ã¯ãªãã§ããããïŒãããããã®ããã«ã¯è°äŒã®ç«æ³ãå¿ èŠã§ããã³ãããã¯ããããæ¿æ²»ãè¡ãè©°ãŸããæããŠããŸãã
æ°äž»å ãšå ¬è¡è¡çåœå±ã¯ãã¯ã¯ãã³ãžã®ç念ãæããããªãè¡åãé¿ããããšèããŠããããã§ããäžæ¹ãå ±åå ã¯ã¯ã¯ãã³æ¥çš®ã®æ¬ ç¹ã«ã€ããŠå£°é«ã«äž»åŒµããŠããã«ããããããã補è¬äŒç€Ÿã«å¯Ÿãã課çšãæ¿èªããŠè¢«å®³è è£åãè³éé¢ã§æ¯ããããšã«ã¯æ¶æ¥µçã§ãã
çŸåšããã¯ã¯ãã³è¢«å®³è£åè¿ä»£åæ³æ¡ãïŒVaccine Injury Compensation Modernization ActïŒãæåºãããŠããŸãããã®æ³æ¡ã¯COVID-19ã¯ã¯ãã³ãVICPã®å¯Ÿè±¡ã«å ãããã®ã§ãããå ±åæç¶ãã®æ¹åãç¹å¥å€äºã®å¢å¡ãç®æãä»ã®æ³æ¡ãšãšãã«ãåæ»ãããŸãŸã§ãã
ç§ã¯ã蚎èšã«ä»£ããåççãªä»£æ¿ææ®µãæ±ããæš©å©ããããšèããŠããŸããã¯ã¯ãã³è¢«å®³è ãæ¯æŽããå£äœReact19ã®æ³åãã£ã¬ã¯ã¿ãŒã§ããã¯ãªã¹ããã¡ãŒã»Aã»ãã©ã€ã¹ãããæ°ãããã³ãããã¯æ¿æ²»ã®ããã«2024幎ã®éžææ¥ãŸã§ã¯äœãé²å±ããªãã ãããšèŠãŠããŸãã
ããã§ããäžéšã®èšŽèšã§ã¯ãæ¿åºã®ã¯ã¯ãã³è¢«å®³è ææžããã»ã¹ãæ²æ³éåã§ãããšäž»åŒµãããŠãããããã補è¬äŒç€Ÿãåãããè°äŒãè¢«å®³è æ¯æŽå£äœãšããç©æ¥µçã«æ¹é©ã«åãçµãŸããå¯èœæ§ããããŸãã
å»çããã³å ¬è¡è¡çã®å°éå®¶ããäŸç¶ãšããŠçµéšçäºå®ãèªããããšãæåŠããŠããããšã¯ãæã倱æãã¹ãç¹ã§ãããã®æ 床ããç«æ³è ãå ¬è¡è¡çåœå±ã«ãäœãããªãããšããå£å®ãäžããŠããã®ã§ãã
äžéšã®å»åž«ã¯ãJïŒJã¯ã¯ãã³ãGBSã®å¯äœçšãåŒãèµ·ãããšããäºå®ãçŸåšãåŠå®ããŠããŸãããŸããGBSã®çåè åãäŒè°ã§ã¯ãããå»åž«ããå¿é ããã«ã¯ã¯ãã³ãæ¥çš®ãã¹ãã ããšè¿°ã¹ãç§ãç°è°ãå±ãããšããŸãã§åã¯ã¯ãã³æŽŸã®ãç人ãã§ãããã®ãããªç®ã§ç§ãèŠãŸããã
äžæ¹ããžã£ãŒããªãºã ã®äžçã§ã¯ãããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºãã忢ãªäŸå€ãšããŠã倧倿°ããã¯ã¯ãã³æ¯æã®æ£çµ±æŽŸãã«åŸã£ãŠããŸãã
ç§ã¯é°è¬è«è ã§ã¯ãããŸããããã ã瀟äŒãšããŠãå ¬æ£ããšéææ§ãå®ã矩åããããšä¿¡ããŠããã ãã§ãã
ç§ã¯ãç§ã«èµ·ãã£ãããšãæ£åŒã«èšé²ããå»çæ¥çã補è¬äŒç€Ÿãããè¯ãã¯ã¯ãã³ãäœãããã«å©çšã§ããããŒã¿ã«è²¢ç®ããããšé¡ã£ãŠããŸãã